Cyclophosphamide for the treatment of progressive low-grade astrocytoma: A Pediatric Oncology Group Phase II study

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 3, 1999, Pages 198-202

  Kadota, Richard P ^a,b   Kun, Larry E ^a   Langston, James W ^a   Burger, Peter C ^a   Cohen, Michael E ^a   Mahoney, Donald H ^a   Walter, Andrew W ^a   Rodman, John H ^a   Parent, Andrew ^a   Buckley, Edward ^a   Kepner, James L ^a   Friedman, Henry S ^a  

^a Pediatric Oncology Group   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Astrocytoma; Cyclophosphamide; Optic glioma; Pediatric brain tumor; Phase II study

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; OPTIC NERVE GLIOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN NEOPLASMS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; HUMANS; INFANT; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 17144472486     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199905000-00007     Document Type: Article

References (25)

1. Landis SH, Taylor M, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. Gajjar A, Sanford RA, Heideman R, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol 1997;8:2792-9.
3. Fisher PG, Tihan T, Goldthwaite PT, et al. All childhood low-grade astrocytomas are not the same: three decades experience at the Johns Hopkins Hospital. (Abstract). Proc Am Soc Clin Oncol 1998;17:535a.
4. Tao ML, Barnes PD, Billett AL, et al. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys 1997;3:579-87.
5. Fisher BJ, Bauman GS, Leighton CE, et al. Low-grade gliomas in children: tumor volume response to radiation. J Neurosurg 1998; 88:969-74.
6. Jenkin D, Angyalfi S, Becker L, et al. Optic glioma in children: surveillance, resection or irradiation? Int J Radiat Oncol Biol Phys 1993;25:215-25.
7. Garvey M, Packer R. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol 1996;28:167-83.
8. Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995;75:1051-9.
9. Friedman HS, Krischer JP, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 1992;2:249-56.
10. Cohen ME, Mahoney Jr DH, Duffner PK, et al. Evaluation of optic pathway tumors: natural history and treatment. Pediatric Oncology Group study preliminary report. (Abstract). Ann Neurol 1994;36: 505.
11. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997;86:747-54.
12. Prados MD, Edwards MSB, Rabbitt J, et al. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 1997;32:235-41.
13. Longee DC, Friedman HS, Albright RE Jr, et al. Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg 1990;72:583-8.
14. Gajjar A, Heideman RL, Kovnar EH, et al. Response of pediatric low grade gliomas to chemotherapy. Pediatr Neurosurg 1993;19: 113-20.
15. Wisoff JH, Abbott R, Epstein F. Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 1990;73:661-7.
16. Hoffman HJ, Soloniuk D, Humphreys RP, et al. Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. Neurosurg 1993;33:964-70.
17. Sutton LN, Molloy PT, Sernyak H, et al. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995;83:583-9.
18. Kovalic JJ, Grigsby PW, Shephard MJ, et al. Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 1990;18:927-32.
19. Bataini JP, Delanian S, Ponvert D. Chiasmal gliomas: results of irradiation management in 57 patients and review of the literature. Int J Radiat Oncol Biol Phys 1991;21:615-23.
20. Mulhern RK, Hancock J, Fairclough D, et al. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 1992;20:181-91.
21. Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998;16: 1723-8.
22. Pons MA, Finlay JL, Walker RW, et al. Chemotherapy with vincristine and etoposide in children with low-grade astrocytoma. J Neuro-Oncol 1992;14:151-8.
23. Moghrabi A, Friedman HS, Ashley DM, et al. Phase II study of carboplatin in progressive low-grade gliomas. Neurosurg Focus 1998;4(4): Article 3.
24. Ater JL, Tarbell NJ, Laws E. Optic nerve, chiasmal, and hypothalamic region tumors. In: Levin VA. ed. Cancer in the nervous system. New York: Churchill Livingstone, 1996:139-51.
25. Pollack IF, Mulvihill JJ. Special issues in the management of gliomas in children with neurofibromatosis. J Neuro-Oncol 1996;28: 257-68.